Search - tctmd.com

Displaying 81 - 100 of 4092

Sort: Relevancy | Date

News Conference News AHA 2025

DECAF: Daily Coffee, Not Abstinence, Beneficial for AF Patients

Michael O'Riordan

November 09, 2025

News Conference News AHA 2025

Stopping DOACs After Successful AF Ablation Feasible in Low-risk Patients: OCEAN

Michael O'Riordan

November 08, 2025

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Michael O'Riordan

November 08, 2025

News Conference News VIVA 2025

ENGULF Novel PE Thrombectomy Device Minimizes Blood Loss

L.A. McKeown

November 07, 2025

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

News Conference News TCT 2025

What Makes MedTech Great—or Not—and Envisioning Its Future

Caitlin E. Cox

November 04, 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

Presentation TCT 2025

TCT 48: Catheter Ablation Versus Antiarrhythmic Drug Therapy for Ventricular Tachycardia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: Michael Sabina

October 28, 2025

Presentation TCT 2025

TCT 1064: Relative Contribution of High Dose Outliers to Cumulative Occupational Radiation Dose in the Catheterization Laboratory

Presenter: Michael Abiragi

October 28, 2025

Presentation TCT 2025

TCT 565: Survival Outcomes in Patients With and Without Devices who Undergo Alcohol Septal Ablation for HOCM

Presenter: Michael Graf

October 28, 2025

Presentation TCT 2025

Surgeon's Viewpoint

Presenter: Michael J. Mack

October 28, 2025

News Conference News TCT 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Todd Neale

October 27, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

Long Term Outcomes After TAV in SAVR: Do We Need A Randomized Trial?

Presenter: Michael A. Borger

October 27, 2025

Presentation TCT 2025

TCT 916: Machine Learning to Predict Neurological Outcome after Out-of-hospital Cardiac Arrest

Presenter: Johannes Michael Altstidl

October 27, 2025

Presentation TCT 2025

What can CDT Accomplish that MT Can’t Do Faster?

Presenter: Michael Young

October 27, 2025

Presentation TCT 2025

Case-Based Panel Discussion: Matching the Right Patient With the Right Device

Presenter: Michael I. Brener

October 27, 2025

Presentation TCT 2025

The Rationale for Pursuing Percutaneous Devices to Reconstruct the Failing Left Ventricle

Presenter: Michael I. Brener

October 27, 2025

Presentation TCT 2025

Commentary

Presenter: Michael J. Reardon

October 27, 2025

Advertisement

DECAF: Daily Coffee, Not Abstinence, Beneficial for AF Patients

Stopping DOACs After Successful AF Ablation Feasible in Low-risk Patients: OCEAN

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

ENGULF Novel PE Thrombectomy Device Minimizes Blood Loss

What’s Going to Be Hot at AHA 2025?

What Makes MedTech Great—or Not—and Envisioning Its Future

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

TCT 48: Catheter Ablation Versus Antiarrhythmic Drug Therapy for Ventricular Tachycardia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

TCT 1064: Relative Contribution of High Dose Outliers to Cumulative Occupational Radiation Dose in the Catheterization Laboratory

TCT 565: Survival Outcomes in Patients With and Without Devices who Undergo Alcohol Septal Ablation for HOCM

Surgeon's Viewpoint

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Long Term Outcomes After TAV in SAVR: Do We Need A Randomized Trial?

TCT 916: Machine Learning to Predict Neurological Outcome after Out-of-hospital Cardiac Arrest

What can CDT Accomplish that MT Can’t Do Faster?

Case-Based Panel Discussion: Matching the Right Patient With the Right Device

The Rationale for Pursuing Percutaneous Devices to Reconstruct the Failing Left Ventricle

Commentary

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content